Targeting the p53-MDM2 interaction by the small-molecule MDM2 antagonist Nutlin-3a: a new challenged target therapy in adult Philadelphia positive acute lymphoblastic leukemia patients

Abstract excerpt

// Stefania Trino 1 , Ilaria Iacobucci 2 , Daniela Erriquez 3 , Ilaria Laurenzana 1 , Luciana De Luca 1 , Anna Ferrari 2 , Andrea Ghelli Luserna Di Rorà 2 , Cristina Papayannidis 2 , Enrico Derenzini 2 , Giorgia Simonetti 2 , Annalisa Lonetti 4 , Claudia Venturi 2 , Federica Cattina 5 , Emanuela Ottaviani 2 , Maria Chiara Abbenante 2 , Domenico Russo 5 , Giovanni Perini 3 , Pellegrino Musto 6 , Giovanni...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Acute Lymphoblastic Leukemia research
• Share to Acute Myeloid Leukemia Research
• Share to Cancer-related Molecular Pathways